TECH
Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products.
Bio-Techne Corporation (TECH) is rated C+ (2.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B+); its weakest is Revisions (D+).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-16 | C- (2.0) | C- (2.0) | B (3.2) | B+ (3.8) | D+ (1.6) | C+ (2.5) |
| 2026-11-09 | C- (2.0) | C- (2.0) | B (3.2) | B+ (3.7) | F (0.3) | C (2.2) |
| 2026-11-02 | C- (2.1) | C- (2.1) | B (3.2) | B (3.4) | F (0.3) | C (2.2) |
| 2026-10-27 | C- (2.1) | C- (2.1) | B (3.2) | B (3.2) | F (0.5) | C (2.2) |
| 2026-10-26 | C- (2.1) | C- (2.1) | B (3.2) | B (3.2) | C- (2.0) | C+ (2.5) |